rs374087499

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001165963.4(SCN1A):​c.4551A>G​(p.Lys1517Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000228 in 1,609,700 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 2 hom. )

Consequence

SCN1A
NM_001165963.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.608

Publications

0 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 2-165996043-T-C is Benign according to our data. Variant chr2-165996043-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 331883.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.608 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000171 (26/151688) while in subpopulation SAS AF = 0.00538 (26/4832). AF 95% confidence interval is 0.00377. There are 0 homozygotes in GnomAd4. There are 19 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 26 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001165963.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
NM_001165963.4
MANE Select
c.4551A>Gp.Lys1517Lys
synonymous
Exon 27 of 29NP_001159435.1P35498-1
SCN1A
NM_001202435.3
c.4551A>Gp.Lys1517Lys
synonymous
Exon 26 of 28NP_001189364.1P35498-1
SCN1A
NM_001353948.2
c.4551A>Gp.Lys1517Lys
synonymous
Exon 25 of 27NP_001340877.1P35498-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
ENST00000674923.1
MANE Select
c.4551A>Gp.Lys1517Lys
synonymous
Exon 27 of 29ENSP00000501589.1P35498-1
SCN1A
ENST00000303395.9
TSL:5
c.4551A>Gp.Lys1517Lys
synonymous
Exon 26 of 28ENSP00000303540.4P35498-1
SCN1A
ENST00000375405.7
TSL:5
c.4518A>Gp.Lys1506Lys
synonymous
Exon 24 of 26ENSP00000364554.3P35498-2

Frequencies

GnomAD3 genomes
AF:
0.000172
AC:
26
AN:
151570
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00538
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000439
AC:
110
AN:
250770
AF XY:
0.000598
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000234
AC:
341
AN:
1458012
Hom.:
2
Cov.:
29
AF XY:
0.000352
AC XY:
255
AN XY:
725368
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33312
American (AMR)
AF:
0.00
AC:
0
AN:
44596
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25996
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39542
South Asian (SAS)
AF:
0.00373
AC:
321
AN:
86052
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5738
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1109260
Other (OTH)
AF:
0.000266
AC:
16
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
151688
Hom.:
0
Cov.:
32
AF XY:
0.000256
AC XY:
19
AN XY:
74158
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41488
American (AMR)
AF:
0.00
AC:
0
AN:
15162
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00538
AC:
26
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67696
Other (OTH)
AF:
0.00
AC:
0
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
Asia WGS
AF:
0.00116
AC:
4
AN:
3470

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Epilepsy (1)
-
-
1
Generalized epilepsy with febrile seizures plus, type 2 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Migraine, familial hemiplegic, 3 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
13
DANN
Benign
0.65
PhyloP100
0.61
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374087499; hg19: chr2-166852553; API